Tele-Optometry leadership 20/20NOW positions itself as a leader and innovator in Tele-Optometry with a large installed base of over 2.75 million exams and a flexible model that enables clinicians to see patients remotely, presenting a strong case for expanding partnerships with optometry clinics and hospital networks seeking scalable exam delivery.

AI driven diagnostics The company leverages FDA approved AI to enhance retinal imaging and assist in early detection of critical eye diseases like diabetic retinopathy, offering a differentiator for value-based selling to providers focusing on quality of care, risk management, and potential reimbursement advantages.

Cost effective expansion No upfront capital investment is required and the service enables six day a week patient access with on-demand doctor coverage, creating a compelling pitch for clinics and hospitals looking to expand exams without capital expenditure while lowering per-exam costs.

Comprehensive exam suite The offering combines proprietary exam algorithms, high tech equipment, and HD telehealth to deliver the most comprehensive non-dilated eye exams, which can be marketed to practices seeking higher-quality assessments, faster turnaround, and improved patient satisfaction.

Revenue growth opportunities With extensive adoption, remote doctor availability, and flexible professional service models, 20/20NOW provides multiple cross-sell avenues to ophthalmology practices, optometry groups, and hospital systems looking to increase patient throughput, reduce staffing gaps, and monetize on-demand eye care.